Role of EBV in microRNA dysregulation in Burkitt lymphoma

Young, 2004, Epstein-Barr virus: 40 years on, Nat Rev Cancer, 4, 757, 10.1038/nrc1452 Thompson, 2004, Epstein-Barr virus and cancer, Clin Cancer Res, 10, 803, 10.1158/1078-0432.CCR-0670-3 Dolcetti, 2005, EBV-associated tumors: pathogenetic insights for improved disease monitoring and treatment, Curr Cancer Ther Rev, 1, 27, 10.2174/1573394052952528 Rezk, 2007, Epstein-Barr virus-associated lymphoproliferative disorders, Hum Pathol, 38, 1293, 10.1016/j.humpath.2007.05.020 Robertson, 2005, Epstein-Barr virus, 35 Anagnostopoulos, 1995, Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus, Blood, 85, 744, 10.1182/blood.V85.3.744.bloodjournal853744 Thorley-Lawson, 2001, Epstein-Barr virus: exploiting the immune system, Nat Rev Immunol, 1, 75, 10.1038/35095584 Thorley-Lawson, 2004, Persistence of the Epstein-Barr virus and the origin of the associated lymphomas, N Eng J Med, 350, 1328, 10.1056/NEJMra032015 Babcock, 2000, Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors, Proc Natl Acad Sci USA, 97, 12250, 10.1073/pnas.200366597 Kurth, 2000, EBV-infected B-cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency, Immunity, 13, 485, 10.1016/S1074-7613(00)00048-0 Kurth, 2003, Epstein-Barr virus-infected cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction, Proc Natl Acad Sci USA, 100, 4730, 10.1073/pnas.2627966100 Hopwood, 2000, The role of EBV in post-transplant malignancies: a review, J Clin Pathol, 53, 248, 10.1136/jcp.53.4.248 Thomas, 1990, Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals, Transplantation, 49, 944, 10.1097/00007890-199005000-00022 Levine, 1993, AIDS-related malignancies: the emerging epidemic, J Natl Cancer Inst, 85, 1382, 10.1093/jnci/85.17.1382 Sbih-Lammali, 1996, Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in north African nasopharyngeal carcinoma, J Med Virol, 49, 7, 10.1002/(SICI)1096-9071(199605)49:1<7::AID-JMV2>3.0.CO;2-A Cesarman, 1999, Virus-associated lymphomas, Curr Opin Oncol, 11, 322, 10.1097/00001622-199909000-00002 Niedobitek, 1997, Epstein-Barr virus infection and the pathogenesis of malignant lymphomas, Cancer Surv, 30, 143 Leoncini, 2008, Burkitt lymphoma, 262 Van Den Bosch, 2004, Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?, Lancet Oncol, 5, 738, 10.1016/S1470-2045(04)01650-X Wright, 1971, Burkitt's lymphoma: a review of the pathology, immunology, and possible etiologic factors, Pathol Annu, 6, 337 Bellan, 2003, Burkitt's lymphoma: new insights into molecular pathogenesis, J Clin Pathol, 56, 188, 10.1136/jcp.56.3.188 Rasti, 2005, Circulating Epstein-Barr virus in children living in malaria-endemic areas, Scand J Immunol, 61, 461, 10.1111/j.1365-3083.2005.01589.x Moormann, 2005, Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children, J Infect Dis, 191, 1233, 10.1086/428910 Gutiérrez, 1992, Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions, Blood, 79, 3261, 10.1182/blood.V79.12.3261.3261 25:Gong, 2003, Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases, Am J Surg Pathol, 27, 818, 10.1097/00000478-200306000-00014 Lazzi, 2002, Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis, Hum Pathol, 33, 723, 10.1053/hupa.2002.125372 De Falco, 2003, Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms, Oncogene, 22, 6214, 10.1038/sj.onc.1206637 Subar, 1988, Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma, Blood, 72, 667, 10.1182/blood.V72.2.667.667 Lazzi, 1998, HIV associated malignant lymphomas in Kenya (Equatorial Africa), Hum Pathol, 29, 1285, 10.1016/S0046-8177(98)90258-1 Ruddell, 2003, B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis, Am J Pathol, 163, 2233, 10.1016/S0002-9440(10)63581-X Cinti, 2000, Genetic alterations disrupting the nuclear localization of the retinoblastoma related gene RB2/p130 in human cell lines and primary tumors, Cancer Res, 60, 383 Cinti, 2000, Genetic alterations of the retinoblastoma related gene RB2/p130 identify different pathogenetic mechanism in and among Burkitt's lymphoma subtypes, Am J Pathol, 156, 751, 10.1016/S0002-9440(10)64941-3 Lindström, 2002, Role of genetic and epigenetic changes in Burkitt lymphoma, Semin Cancer Biol, 12, 381, 10.1016/S1044-579X(02)00058-5 Dave, 2006, Molecular diagnosis of Burkitt's lymphoma. Lymphoma/leukemia molecular profiling project, N Engl J Med, 354, 2431, 10.1056/NEJMoa055759 Hummel, 2006, Molecular mechanisms in malignant lymphomas network project of the deutsche krebshilfe. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling, N Engl J Med, 354, 2419, 10.1056/NEJMoa055351 Leucci, 2008, MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation, J Pathol, 216, 440, 10.1002/path.2410 Spina, 1997, Cellular Kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas, J Pathol, 182, 145, 10.1002/(SICI)1096-9896(199706)182:2<145::AID-PATH819>3.0.CO;2-P Baran-Marszak, 2002, Gene array identification of Epstein-Barr virus regulated cellular genes in EBV converted Burkitt lymphoma cell lines, Lab Invest, 82, 1463, 10.1097/01.LAB.0000035025.51772.2B Bellan, 2005, Immunoglobulin gene analysis reveals two distinct cells of origin for EBV positive and EBV negative Burkitt's lymphomas, Blood, 106, 1031, 10.1182/blood-2005-01-0168 Kuo, 2007, Repression of BCL-6 is required for the formation of human memory B cells in vitro, J Exp Med, 204, 819, 10.1084/jem.20062104 Shapiro-Shelef, 2003, Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells, Immunity, 19, 607, 10.1016/S1074-7613(03)00267-X Kallies, 2007, Terminal differentiation of lymphocytes depends on Blimp-1, Curr Opin Immunol, 19, 156, 10.1016/j.coi.2007.01.003 Asirvatham, 2008, MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components, Mol Immunol, 45, 1995, 10.1016/j.molimm.2007.10.035 Zhao, 2007, A developmental view of microRNA function, Trends Biochem Sci, 32, 189, 10.1016/j.tibs.2007.02.006 Leucci, 2009, B cell differentiation in EBV-positive Burkitt Lymphoma is impaired at post-transcriptional level by miRNA altered expression, Int J Cancer Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Cullen, 2004, Transcription and processing of human microRNA precursors, Mol Cell, 16, 861, 10.1016/j.molcel.2004.12.002 He, 2004, MicroRNAs: small RNAs with a big role in gene regulation, Nat Rev Genet, 5, 522, 10.1038/nrg1379 Calin, 2004, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, Proc Natl Acad Sci USA, 101, 2999, 10.1073/pnas.0307323101 Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci USA, 103, 2257, 10.1073/pnas.0510565103 Lawrie, 2007, MicroRNAs and haematology: small molecules, big function, Br J Haematol, 137, 503, 10.1111/j.1365-2141.2007.06611.x Lawrie, 2007, MicroRNA expression in lymphoma, Expert Opin Biol Ther, 7, 1363, 10.1517/14712598.7.9.1363 Kaul, 2009, Mol Cell Biochem, 323, 143, 10.1007/s11010-008-9973-4 Scaria, 2007, Host-virus genome interactions: macro roles for microRNAs, Cell Microbiol, 9, 2784, 10.1111/j.1462-5822.2007.01050.x Godshalk, 2008, Epstein-Barr virus-mediated dysregulation of human microRNA expression, Cell Cycle, 7, 3595, 10.4161/cc.7.22.7120 Yin, 2008, MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways, J Virol, 82, 5295, 10.1128/JVI.02380-07 Lu, 2008, Epstein-Barr virus-induced miR-155 attenuates NF-kB signaling and stabilizes latent virus persistence, J Virol, 82, 10436, 10.1128/JVI.00752-08 Bornkamm, 2009, Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers, Int J Cancer, 124, 1745, 10.1002/ijc.24223 Gottwein, 2007, A viral microRNA functions as an orthologue of cellular miR-155, Nature, 450, 1096, 10.1038/nature05992 Lenze D, Hummel M, Jöhrens K, Leucci E, Onnis A, Leoncini L et al., MicroRNA expression profiling of mature aggressive B-cell lymphoma with special reference to sporadic and endemic Burkitt lymphoma. International conference on Burkitt lymphoma. J Hematopathol 2008; 1: 47-74.